# Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

> **NCT00002949** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 33 (actual)

## Conditions studied

- Bladder Cancer
- Cervical Cancer
- Endometrial Cancer
- Vaginal Cancer

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** vinorelbine tartrate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002949
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 2000-11
- **Final completion:** 2001-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002949, "Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*